购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空
筛选
已筛选:全部清除
TargetMol | Tags 通过 靶点 筛选
  • Glucagon Receptor
    (1)
  • Others
    (1)
TargetMol | Tags 通过 货期 筛选
  • 现货
    (1)
  • 5日内发货
    (1)
  • 35日内发货
    (1)
筛选
搜索结果
TargetMol产品目录中 "

glp1(737)

"的结果
  • 抑制剂&激动剂
    3
    TargetMol | Inhibitors_Agonists
  • 多肽产品
    2
    TargetMol | Peptide_Products
  • GLP-1(7-37)
    人胰高血糖素样肽-1
    TP1306106612-94-6
    GLP-1 (7-37) is a truncated, bioactive form of GLP-1 that is the product of proglucagon processing in intestinal endocrine L cells.
    • 待估
    35日内发货
    规格
    数量
  • GLP-1(7-37) acetate(106612-94-6 free base)
    GLP-1(7-37) acetate
    TP13761450806-98-0
    GLP-1(7-37) acetate 是肠道胰岛素激素,能够促进葡萄糖诱导的胰岛素分泌。
    • ¥ 1150
    In stock
    规格
    数量
    TargetMol | Inhibitor Sale
  • GLP-1(7-37) TFA salt
    T64553
    The truncated glucagon-like peptides GLP-1(7-37) is naturally occurring peptide product of the preproglucagon gene that are synthesized primarily in the intestine and acts as incretin that are released from the intestine into the bloodstream in response to food and stimulate insulin secretion. GLP-1(7-37) produced a dose-related enhancement of the glucose-stimulated increase in plasma insulin concentration and an increased rate of glucose infusion in Sprague-Dawley Rats at a dosing rang of 0.5, 5, or 50 pmol min kg. Further, infusion of GLP-1(7-37) for 60 mins produced a small transitory increase in plasma insulin concentration in fasted rats and fed rats and a slight transitory decrease in plasma glucose concentration. Moreover, GLP-1(7-37) (5 pmol min kg IV) infusion for 6 h in Sprague-Dawley rats produced a sustained increase in plasma insulin concentration relative to levels in rats infused with vehicle[1].
    • ¥ 1997
    5日内发货
    规格
    数量